These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3182418)

  • 1. Cefodizime in acute purulent exacerbations of chronic respiratory disease.
    Maesen FP; Davies BI; Baur C; Sumajow CA
    J Antimicrob Chemother; 1988 Aug; 22(2):229-35. PubMed ID: 3182418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.
    Maesen FP; Davies BI; van den Bergh JJ; Gubbelmans HL; Meek JC; Geraedts WH
    J Antimicrob Chemother; 1990 Mar; 25(3):413-22. PubMed ID: 2187013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; van den Bergh JJ; Costongs RJ; Geraedts WH; Gubbelmans HL; Meek JC
    Infection; 1992; 20 Suppl 1():S22-5. PubMed ID: 1526671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP
    J Antimicrob Chemother; 1984 Dec; 14(6):653-60. PubMed ID: 6097574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and pharmacokinetic study on cefodizime, a new cephalosporin antibiotic, in the pediatric infections].
    Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T
    Jpn J Antibiot; 1989 Jun; 42(6):1293-305. PubMed ID: 2795854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
    Mazzei T; Novelli A; Esposito S; Fallani S; Noviello S; Cassetta MI; Conti S; Periti P
    J Chemother; 2000 Aug; 12(4):306-13. PubMed ID: 10949980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Brogden RN
    Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():65-70. PubMed ID: 2074253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open multicentre study of the efficacy and tolerance of cefodizime 1 g bd intravenously or intramuscularly in lower respiratory tract infections.
    Sollet JP
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():103-10. PubMed ID: 2074244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
    Pruksachatvuthi S; Aswapokee N; Aswapokee P
    J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefodizime: a review of the data on file.
    Barré J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():95-101. PubMed ID: 2074258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of cefodizime in children.
    Boccazzi A; Fusi G; Mezzopane AM; Maretti M; Careddu P
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():83-7. PubMed ID: 2074256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical studies on cefodizime in the pediatric field. Pediatric Study Group of Cefodizime].
    Fujii R; Arimasu O; Meguro H; Hiruma F; Sugie N; Abe T; Nakazawa S; Sato H; Narita A; Matsumoto K
    Jpn J Antibiot; 1989 May; 42(5):1173-93. PubMed ID: 2664256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefodizime, an aminothiazolylcephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series.
    Blumbach J; Dürckheimer W; Ehlers E; Fleischmann K; Klesel N; Limbert M; Mencke B; Reden J; Scheunemann KH; Schrinner E
    J Antibiot (Tokyo); 1987 Jan; 40(1):29-42. PubMed ID: 3558116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
    Palombini BC; André-Alves MR; Dagrosa EE
    Arzneimittelforschung; 1997 Mar; 47(3):299-302. PubMed ID: 9105549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
    el Guinaidy MA; Nawishy S; Abd el Bary M; Sabbour MS
    Chemotherapy; 1991; 37(2):77-85. PubMed ID: 2032473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.